• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定和表征寨卡病毒 NS5 甲基转移酶抑制剂。

Identification and Characterization of Zika Virus NS5 Methyltransferase Inhibitors.

机构信息

State Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

Front Cell Infect Microbiol. 2021 Apr 7;11:665379. doi: 10.3389/fcimb.2021.665379. eCollection 2021.

DOI:10.3389/fcimb.2021.665379
PMID:33898335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8058401/
Abstract

The recurring outbreak of Zika virus (ZIKV) worldwide makes an emergent demand for novel, safe and efficacious anti-ZIKV agents. ZIKV non-structural protein 5 (NS5) methyltransferase (MTase), which is essential for viral replication, is regarded as a potential drug target. In our study, a luminescence-based methyltransferase assay was used to establish the ZIKV NS5 MTase inhibitor screening model. Through screening a natural product library, we found theaflavin, a polyphenol derived from tea, could inhibit ZIKV NS5 MTase activity with a 50% inhibitory concentration (IC) of 10.10 μM. Molecular docking and site-directed mutagenesis analyses identified D146 as the key amino acid in the interaction between ZIKV NS5 MTase and theaflavin. The SPR assay indicated that theaflavin had a stronger binding activity with ZIKV NS5 wild-type (WT)-MTase than it with D146A-MTase. Moreover, theaflavin exhibited a dose dependent inhibitory effect on ZIKV replication with a 50% effective concentration (EC) of 8.19 μM. All these results indicate that theaflavin is likely to be a promising lead compound against ZIKV.

摘要

寨卡病毒(ZIKV)在全球范围内反复爆发,这就迫切需要新型、安全且有效的抗寨卡病毒药物。寨卡病毒非结构蛋白 5(NS5)甲基转移酶(MTase)是病毒复制所必需的,被认为是一个潜在的药物靶点。在本研究中,我们建立了基于发光的甲基转移酶检测法,用于寨卡病毒 NS5 MTase 抑制剂的筛选模型。通过对天然产物库进行筛选,我们发现茶黄素,一种源自茶叶的多酚类物质,能够以 50%抑制浓度(IC₅₀)为 10.10 μM 的浓度抑制寨卡病毒 NS5 MTase 活性。分子对接和定点突变分析鉴定出 D146 是寨卡病毒 NS5 MTase 与茶黄素相互作用的关键氨基酸。SPR 分析表明,茶黄素与寨卡病毒 NS5 野生型(WT)-MTase 的结合活性强于与 D146A-MTase 的结合活性。此外,茶黄素对寨卡病毒复制表现出剂量依赖性抑制作用,其 50%有效浓度(EC₅₀)为 8.19 μM。所有这些结果表明,茶黄素可能是一种有前途的抗寨卡病毒先导化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f39/8058401/1c2bfd5f7a61/fcimb-11-665379-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f39/8058401/424dc60f31fb/fcimb-11-665379-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f39/8058401/7334d9a7e7fd/fcimb-11-665379-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f39/8058401/09fa1fde242d/fcimb-11-665379-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f39/8058401/022f70597c96/fcimb-11-665379-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f39/8058401/1c2bfd5f7a61/fcimb-11-665379-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f39/8058401/424dc60f31fb/fcimb-11-665379-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f39/8058401/7334d9a7e7fd/fcimb-11-665379-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f39/8058401/09fa1fde242d/fcimb-11-665379-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f39/8058401/022f70597c96/fcimb-11-665379-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f39/8058401/1c2bfd5f7a61/fcimb-11-665379-g005.jpg

相似文献

1
Identification and Characterization of Zika Virus NS5 Methyltransferase Inhibitors.鉴定和表征寨卡病毒 NS5 甲基转移酶抑制剂。
Front Cell Infect Microbiol. 2021 Apr 7;11:665379. doi: 10.3389/fcimb.2021.665379. eCollection 2021.
2
Zika Virus Methyltransferase: Structure and Functions for Drug Design Perspectives.寨卡病毒甲基转移酶:药物设计视角下的结构与功能
J Virol. 2017 Feb 14;91(5). doi: 10.1128/JVI.02202-16. Print 2017 Mar 1.
3
A cell-based assay to discover inhibitors of Zika virus RNA-dependent RNA polymerase.一种用于发现寨卡病毒RNA依赖性RNA聚合酶抑制剂的基于细胞的检测方法。
Virology. 2024 Jan;589:109939. doi: 10.1016/j.virol.2023.109939. Epub 2023 Nov 11.
4
The crystal structure of Zika virus NS5 reveals conserved drug targets.寨卡病毒NS5的晶体结构揭示了保守的药物靶点。
EMBO J. 2017 Apr 3;36(7):919-933. doi: 10.15252/embj.201696241. Epub 2017 Mar 2.
5
Identification of Potent Zika Virus NS5 RNA-Dependent RNA Polymerase Inhibitors Combining Virtual Screening and Biological Assays.鉴定强效寨卡病毒 NS5 RNA 依赖性 RNA 聚合酶抑制剂:虚拟筛选与生物测定相结合。
Int J Mol Sci. 2023 Jan 18;24(3):1900. doi: 10.3390/ijms24031900.
6
Identification of Novel Non-Nucleoside Inhibitors of Zika Virus NS5 Protein Targeting MTase Activity.鉴定靶向 Zika 病毒 NS5 蛋白甲基转移酶活性的新型非核苷抑制剂。
Int J Mol Sci. 2024 Feb 19;25(4):2437. doi: 10.3390/ijms25042437.
7
NS5 from Dengue Virus Serotype 2 Can Adopt a Conformation Analogous to That of Its Zika Virus and Japanese Encephalitis Virus Homologues.登革热病毒 2 型 NS5 可采用与寨卡病毒和日本脑炎病毒同源物类似的构象。
J Virol. 2019 Dec 12;94(1). doi: 10.1128/JVI.01294-19.
8
Structure of the NS5 methyltransferase from Zika virus and implications in inhibitor design.寨卡病毒NS5甲基转移酶的结构及其在抑制剂设计中的意义。
Biochem Biophys Res Commun. 2017 Oct 28;492(4):624-630. doi: 10.1016/j.bbrc.2016.11.098. Epub 2016 Nov 17.
9
Structural Insight into NS5 of Zika Virus Leading to the Discovery of MTase Inhibitors.寨卡病毒 NS5 的结构洞察导致 MTase 抑制剂的发现。
J Am Chem Soc. 2016 Dec 21;138(50):16212-16215. doi: 10.1021/jacs.6b10399. Epub 2016 Dec 6.
10
Identification of a Small Interface between the Methyltransferase and RNA Polymerase of NS5 that is Essential for Zika Virus Replication.鉴定 NS5 甲基转移酶和 RNA 聚合酶之间的一个小界面,该界面对于寨卡病毒复制是必需的。
Sci Rep. 2018 Nov 26;8(1):17384. doi: 10.1038/s41598-018-35511-3.

引用本文的文献

1
Structural basis for broad-spectrum binding of AT-9010 to flaviviral methyltransferases.AT-9010与黄病毒甲基转移酶广谱结合的结构基础。
Arch Virol. 2025 Feb 20;170(3):61. doi: 10.1007/s00705-025-06227-3.
2
Prodigiosin Demonstrates Promising Antiviral Activity Against Dengue Virus and Zika Virus in In-silico Study.灵菌红素在计算机模拟研究中显示出对登革热病毒和寨卡病毒有前景的抗病毒活性。
Anal Sci Adv. 2024 Nov 7;5(11-12):e202400039. doi: 10.1002/ansa.202400039. eCollection 2024 Dec.
3
Development of a luminescence-based method for measuring West Nile Virus MTase activity and its application to screen for antivirals.

本文引用的文献

1
Tea Polyphenols EGCG and Theaflavin Inhibit the Activity of SARS-CoV-2 3CL-Protease .茶多酚表没食子儿茶素没食子酸酯(EGCG)和茶黄素抑制新型冠状病毒3CL蛋白酶的活性。
Evid Based Complement Alternat Med. 2020 Sep 16;2020:5630838. doi: 10.1155/2020/5630838. eCollection 2020.
2
The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.抗 SARS-CoV-2 RNA 依赖的 RNA 聚合酶的潜在化学结构。
J Med Virol. 2020 Jun;92(6):693-697. doi: 10.1002/jmv.25761. Epub 2020 Mar 18.
3
Importance of Zika Virus NS5 Protein for Viral Replication.
一种基于发光的西尼罗河病毒甲基转移酶活性检测方法的开发及其在抗病毒药物筛选中的应用。
Curr Res Microb Sci. 2024 Oct 2;7:100282. doi: 10.1016/j.crmicr.2024.100282. eCollection 2024.
4
Distinct Replication Kinetics, Cytopathogenicity, and Immune Gene Regulation in Human Microglia Cells Infected with Asian and African Lineages of Zika Virus.亚洲和非洲谱系寨卡病毒感染人类小胶质细胞后的不同复制动力学、细胞致病性及免疫基因调控
Microorganisms. 2024 Sep 5;12(9):1840. doi: 10.3390/microorganisms12091840.
5
screening for potential inhibitors from the phytocompounds of against Zika virus NS5 protein.从植物化合物中筛选针对寨卡病毒 NS5 蛋白的潜在抑制剂。
F1000Res. 2024 Jun 25;12:655. doi: 10.12688/f1000research.134956.2. eCollection 2023.
6
Recent advances in the study of zika virus structure, drug targets, and inhibitors.寨卡病毒结构、药物靶点及抑制剂研究的最新进展
Front Pharmacol. 2024 Jul 1;15:1418516. doi: 10.3389/fphar.2024.1418516. eCollection 2024.
7
endosymbionts in regulate the resistance to Zika virus infection in a sex dependent manner.内共生体以性别依赖的方式调节对寨卡病毒感染的抗性。
Front Microbiol. 2024 Jun 5;15:1380647. doi: 10.3389/fmicb.2024.1380647. eCollection 2024.
8
Construction of recombinant fluorescent LSDV for high-throughput screening of antiviral drugs.构建重组荧光 LSDV 用于高通量筛选抗病毒药物。
Vet Res. 2024 Mar 16;55(1):33. doi: 10.1186/s13567-024-01281-2.
9
Docking and MM study of non-structural protein (NS5) of Japanese Encephalitis Virus (JEV) with some derivatives of adenosyl.日本脑炎病毒(JEV)非结构蛋白(NS5)与腺苷某些衍生物的对接及分子力学研究
Front Chem. 2023 Nov 27;11:1258764. doi: 10.3389/fchem.2023.1258764. eCollection 2023.
10
Broad-Spectrum Small-Molecule Inhibitors Targeting the SAM-Binding Site of Flavivirus NS5 Methyltransferase.靶向黄病毒 NS5 甲基转移酶 SAM 结合位点的广谱小分子抑制剂。
ACS Infect Dis. 2023 Jul 14;9(7):1319-1333. doi: 10.1021/acsinfecdis.2c00571. Epub 2023 Jun 22.
寨卡病毒NS5蛋白对病毒复制的重要性。
Pathogens. 2019 Sep 30;8(4):169. doi: 10.3390/pathogens8040169.
4
Identification and characterization of Zika virus NS5 RNA-dependent RNA polymerase inhibitors.鉴定和表征 Zika 病毒 NS5 RNA 依赖的 RNA 聚合酶抑制剂。
Int J Antimicrob Agents. 2019 Oct;54(4):502-506. doi: 10.1016/j.ijantimicag.2019.07.010. Epub 2019 Jul 13.
5
Antimalarial drugs and their metabolites are potent Zika virus inhibitors.抗疟药物及其代谢物是强效寨卡病毒抑制剂。
J Med Virol. 2019 Jul;91(7):1182-1190. doi: 10.1002/jmv.25440. Epub 2019 Mar 4.
6
Design, synthesis and in vitro anti-Zika virus evaluation of novel Sinefungin derivatives.新型 Sinefungin 衍生物的设计、合成及体外抗 Zika 病毒活性评价。
Eur J Med Chem. 2018 Sep 5;157:994-1004. doi: 10.1016/j.ejmech.2018.08.057. Epub 2018 Aug 23.
7
Zika virus, vaccines, and antiviral strategies.寨卡病毒、疫苗和抗病毒策略。
Expert Rev Anti Infect Ther. 2018 Jun;16(6):471-483. doi: 10.1080/14787210.2018.1483239. Epub 2018 Jun 28.
8
Synthesis of Theaflavins and Their Functions.茶黄素的合成及其功能
Molecules. 2018 Apr 16;23(4):918. doi: 10.3390/molecules23040918.
9
Infection by Zika viruses requires the transmembrane protein AXL, endocytosis and low pH.寨卡病毒的感染需要跨膜蛋白 AXL、内吞作用和低 pH 值。
Virology. 2018 May;518:301-312. doi: 10.1016/j.virol.2018.03.009. Epub 2018 Mar 22.
10
Structure and function of Zika virus NS5 protein: perspectives for drug design.寨卡病毒 NS5 蛋白的结构与功能:药物设计的视角。
Cell Mol Life Sci. 2018 May;75(10):1723-1736. doi: 10.1007/s00018-018-2751-x. Epub 2018 Feb 8.